Szarvas, Tibor; Sevcenco, S; Módos, Orsolya; Keresztes, Dávid; Nyirády, Péter; Kubik, András; Romics, Miklós; Kovalszky, Ilona; Reis, H; Hadaschik, B; Shariat, SF; Kramer, G
(2018)
OBJECTIVES: Docetaxel chemotherapy is a standard treatment for castration-resistant prostate cancer (CRPC). Rapidly expanding treatment options for CRPC provide reasonable alternatives for those who are resistant to ...